Tilbage til menuen

2008


N0.	Author	Title	Media
1.	Ashina M, Jensen R.	Et nyt behandlingsprincip.	Ugeskrift for Laeger 2008; 170:1029.
2.	Ballegaard V, Thede-Schmidt-Hansen P, Svensson P, Jensen R.	Are headache and temporomandibular disorders related? A blinded study.	Cephalalgia 2008; 28:832-841.
3.	Bendtsen L., Jensen R.	Pharmacological and non-pharmacological management of tension-type headache	Eur Neurological review 2008; 3:119-122.
4.	Boiusse V, Calvetti O, Drebz-Botsch CD, Sathornsumetee B, Newman NJ, Frederiksen JL.	Management of optic neuritis and impact of trials. An international survey.	J Neurol sci 2008;
5.	Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R.	Increased pain sensitivity is not a risk factor but a consequence of frequent headache: a population-based follow-up study.	Pain 2008; 137:623-630.
6.	Christiansen I, Iversen HK, Olesen J, Tfelt-Hansen P.	Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate.	Headache Pain 2008; 9:215-220.
7.	Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B.	Predictors of migraine headache recurrence: A pooled analysis from the eletriptan database.	Headache 2008; 48:184-193.
8.	Edvinsson L, Tfelt-Hansen P.	The blood-brain barrier in migraine treatment.	Cephalalgia 2008; 28:1245-1258.
9.	Ethic Subcommittee of the International Headache Society, Tfelt-Hansen P.	Ethical issues arising from commercial sponsorship and from relationship with the pharmaceutical industry-report and recommendations of the Ethics Committee of the International Headache Society.	Cephalalgia 2008; 28:1-25.
10.	Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain.	Fabricius M, Fuhr S, Willumsen L, Dreier JP, Bhatia R, Boutelle MG, Hartings JA, Bullock R, Strong AJ, Lauritzen M.	Clinical Neurophysiology 2008; 119:1973-1984.
11.	Gozalov A, Jansen-Olesen I, Klaerke D, Olesen J.	Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.	Headache 2008; 48:1202-1213.
12.	Hansen JM, Thomsen LL, Olesen J, Ashina M.	Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.	Neurology 2008; 71:841-847.
13.	Hansen JM, Thomsen LL, Olesen J, Ashina M.	Familial hemiplegic migraine type 1 shows no hypersensitivity to nitric oxide.	Cephalalgia 2008; 28:496-505.
14.	Hansen JM, Thomsen LL, Marconi R, Casari G, Olesen J, Ashina M.	Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine.	Cephalalgia 2008; 28:367-375.
15.	Jensen R, Bendtsen L.	Medication overuse in Scandinavia. Headache Currents.	Cephalalgia 2008; 28:1237-1239.
16.	Jensen R, Stovner LJ.	Epidemiology and comorbidity of headache.	Lancet Neurol 2008; 7:354-361.
17.	Kallenbach K, Frederiksen JL.	Unilateral optic neuritis as the presenting symptom of human immunodeficiency virus toxoplasmosis infection.	Acta Ophthalmol 2008; 86:459-460.
18.	Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL.	Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.	Mult Scler 2008; 14:734-738.
19.	Korsholm K, Madsen KH, Frederiksen JL, Rowe JB, Lund TE.	Cortical neuroplasticity in patients recovering from acute optic neuritis.	Neuroimage 2008; 42:836-844.
20.	Lassen LH, Jacobsen VB, Haderslev PA, Sperling B, Iversen HK, Olesen J, Tfelt-Hansen P.	Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.	J Headache Pain 2008; 9:151-157.
21.	Linnet K, Steentoft A, Simonsen KW, Sabers A, Hansen SH.	An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases.	Forensic Sci Int 2008; 177:248-251.
22.	Mett A, Tfelt-Hansen P.	Acute migraine therapy: recent evidence from randomized comparative trials.	Current Opinion in Neurology 2008; 21:331-337.
23.	Olesen J.	The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache.	Pharmacol Ther 2008; 120:157-171.
24.	Olesen J, Sobscki P, Truelsen T, Sestoft D, Jonsson B.	Cost of disorders of the brain in Denmark.	Nord J Psychiatry 2008; 62:114-120.
25.	Olesen J.	The International Classification of Headache Disorders.	Headache 2008; 48:691-693.
26.	Ploug KB, Sorensen MA, Strobech L, Klaerke DA, Hay-Schmidt A, Sheykhzade M, Olesen J, Jansen-Olesen I.	K(ATP) channels in pig and human intracranial arteries.	Eur J Pharmacol 2008.
27.	Ploug KB, Boni LJ, Baun M, Hay-Schmidt A, Olesen J, Jansen-Olesen I.	K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.	Br J Pharmacol 2008; 154:72-81.
28.	Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M.	Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine.	Cephalalgia 2008; 28:226-236.
29.	Rogojan C, Tfelt-Hansen P.	[Numbness of the chin as a paraneoplastic syndrome]. Ugeskr	Laeger 2008; 170:3135-3136.
30.	Sabers A.	Pharmacokinetic interactions between contraceptives and antiepileptic drugs.	Seizure 2008; 17:141-144.
31.	Sabroe TP, Sabers A.	Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product.	Acta Neurol Scand 2008; 117:428-431.
32.	Schytz H, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M.	PACAP38 induces migraine-like attacks in patients with migraine without aura.	Brain 2008; dec.:1093.
33.	Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ.	Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.	Cephalalgia 2008; 28:484-495.
34.	Stefansson H, Rujescu D, Cichon S, Pietilainen OPH, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge DL, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, St Clair D, Stefansson K.	Large recurrent microdeletions associated with schizophrenia.	Nature 2008; 455:232-U61.
35.	Tassorelli C, Sances G, Allena M, Ghiotto N, Bendtsen L, Olesen J, Nappi G, Jensen R.	The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres.	Cephalalgia 2008; 28:1023-1030.
36.	Tfelt-Hansen P.	Parenteral versus oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment.	J Headache Pain 2008; 8:273-276.
37.	Tfelt-Hansen P, Koehler PJ.	History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.	Cephalalgia 2008; 28:877-886.
38.	Tfelt-Hansen P, Ashina M, Olesen J.	[Clinical symptoms and pathophysiology of migraine].	Ugeskr Laeger 2008; 170:3231-3234.
39.	Tfelt-Hansen P, Thorbjorn JL, Olesen J.	Delayed hyperperfusion following migraine with a prolonged aphasic aura in a patient with CADASIL.	Cephalalgia 2008; 28:899-902.
40.	Tfelt-Hansen P, Bjarnason NH, Dahlof C, Derry S, Loder E, Massiou H.	Evaluation and registration of adverse events in clinical drug trials in migraine.	Cephalalgia 2008; 28:683-688.
41.	Tfelt-Hansen P, Brosen K.	Pharmacogenomics and migraine: possible implications.	J Headache Pain 2008; 9:13-18.
42.	Thomsen LL, Oestergaard E, Bjornsson A, Stefansson H, Fasquel AC, Gulcher J, Stefansson K, Olesen J.	Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients.	Cephalalgia 2008; 28:914-921.
43.	Wienecke T, Hansen JM, Petersen J, Olsen KS, Ashina M, Tfelt-Hansen P.	Sumatriptan does not affect arteriovenous oxygen differences in jugular and cubital veins in normal human subjects.	Cephalalgia 2008; 28:1081-1085.
44.	Wienecke T, Olesen J, Oturai PS, Ashina M.	Prostacyclin (epoprostenol) induces headache in healthy subjects.	Pain 2008; 139:106-116.
45.	Wulf H, Hay-Schmidt A, Poulsen AN, Klaerke DA, Olesen J, Jansen-Olesen I.	Molecular studies of BK(Ca) channels in intracranial arteries: presence and localization.	Cell Tissue Res 2008.
46.	Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BPL, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW, the PRoFESS Study Group.	Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events.	N Engl J Med 2008; 359:1225-1237.
47.	Zeeberg P, Olesen J, Jensen R.	Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.	Cephalalgia 2008.
48.	Buchgreitz L, Egsgaard LL, Jensen R, Arendt-Nielsen L, Bendtsen L.	Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study.	Brain 2008; 131(Pt 12):3232-3238.
	Bookchapters in International textbooks
1.	Bendtsen L.	Tension-type headache. In: MacGregor A, Jensen J, editors. Migraine and other primary headaches.	London: Oxford University Press; 2008. p. 103-12.
2.	Bendtsen L, Jensen R.	Epidemiology of headache. In: Fernández de las Peñas C, Arendt- Nielsen L, Gerwin RD, editors. Physicaltherapy for tension-type and cervicogenic headache: physical examination, muscle and joint management.	Jones and Barnett; 2008. p. 7-13.
3.	Jensen R.	Tension-type Headache. In: MacGregor A, Jensen R, editors. Migraine and other Primery Headaches.	London: Oxford University Press; 2008. p. 23-30.
4.	Jensen R.	Calcitonin gene-related peptide and 5-hydroxytryptamine modulators. In: Olesen J, Remadan N, editors. Innovative drug development for headache disorders.	Frontiers in Headache research. 2008. p. 129-30.
5.	Jensen R, Torelli P.	Treatment of Tension-type Headache. Handbook of clinical Neurology.	Press; 2008.
6.	Tfelt-Hansen P, Jensen R.	Headache. In: Jensen TS, Wilson PR, Rice ASC, editors. Clinical pain management. Chronic pain. 2 ed.	London: Hodder Arnold Publisherss; 2008. p. 450-66.
7.	Tfelt-Hansen P, Jensen R.	Headache. Clinical pain Management.	Press; 2008.
8.	Tfelt-Hansen P, Jensen R.	Headache. Handbook of Clinical Neurology.	IN press; 2008.
9.	Torelli P, Jensen R.	Diagnosis of headache. Handbook of clinical Neurology.	Press; 2008.






















	Textbooks
1.	MacGregor A, Jensen R.	Migraine and other Primary Headaches.	London: Oxford University Press; 2008.
2.	Olesen J, Ramadan N.	Innovative Drug Development for Headache Disorders.	Oxford: Oxford University Press; 2008.


















	PhD Thesis University of Copenhagen
1.	Buchgreitz L.	Pain processing in tension-type headache.	Københavns Universitet. Det Sundhedsvidenskabe lige Fakultet, 2008.
2.	Gozalov A.	Role of K+ channels in cephalic vasodilatation - implications for migraine pathophysiology	Københavns Universitet. Det sundhedsvidenskabe lige Fakultet. 2008.
3.	Kruse LS.	Molecular mechanisms involving cyclic nucleotides in migraine.	Københavns Universitet. Det sundhedsvidenskabe lige fakultet. 2008.
4.	Ploug KB.	Katp channels in intracranial arteries – implications for migraine pathophysiology.	Københavns Universitet. Det sundhedsvidenskabe lige fakultet. 2008.
5.	Schmidt-Hansen PT.	A controlled study on muscle pain sensitivity in Tension-Type Headache patients	Aarhus Universitet og Københavns Universitet. Det sundhedsvidenskabe lige fakultet. 2008.
6.	Boni LJ.	In vivo studies on the effect on neuropeptides on rat intracranial arteries.	Københavns Universitet. Det sundhedsvidenskabe lige fakultet. 2008.

Redaktør

Editor/webmaster Ditte Sjølund
Email RVYcioap@3pm.regionh.dk

DHC

Danish Headache Center

Contact:

Danish Headache Center
DHC Glostrup Hospital Nord
Building 14
Ndr. Ringvej 69
DK-2600 Glostrup
Denmark

Phone: +45 38 63 20 62
Fax: +45 38 63 38 39

Location of Danish Headache Center - MAP